氟哌噻吨美利曲辛联合艾司唑仑治疗功能性消化不良的临床分析  

Clinical Analysis of Flupentixol and Melitracen Tablets in Combination With Estazolam in Treatment of Functional Dyspepsia

作　　者：刘全利[1] 黄杰[1] 顾仁莲[1] 孙慧洁[1] 

机构地区：[1]吉化集团公司总医院,吉林132022

出　　处：《中国继续医学教育》2016年第3期161-162,共2页China Continuing Medical Education

摘　　要：目的分析氟哌噻吨美利曲辛联合艾司唑仑治疗功能性消化不良的临床效果。方法将功能性消化不良患者78例分为对照组(氟哌噻吨美利曲辛治疗)与观察组(氟哌噻吨美利曲辛+艾司唑仑治疗),对比分析两组患者总有效率及HAMD评分。结果两组总有效率比较,差异有统计学意义(P<0.05);治疗前,两组患者HAMD评分比较,无统计学差异(P>0.05);治疗后,观察组患者HAMD评分低于对照组,差异有统计学意义(P<0.05)。结论氟哌噻吨美利曲辛联合艾司唑仑治疗功能性消化不良的临床效果显著。Objective To analyze the effect of Flupentixol and melitracen tablets and estazolam in the treatment of functional dyspepsia. Methods 78 cases of functional dyspepsia patients were divided into the control group（Flupentixol and melitracen tablets treatment） and observation group（Flupentixol and melitracen tablets ＋ estazolam treatment）, compared two groups of patients with total effective rate and HAMD scores. Results The difference between total effective rate was significant（P〈0. 05）. Before treatment, HAMD scores between the two groups had no significant difference（P〈0. 05）, after treatment, the HAMD scores in observation group were lower than the control group, the difference was significantly（P〈0. 05）. Conclusion Clinical effect of Flupentixol and melitracen tablets andestazolam in functional dyspepsia is significant.

关 键 词：氟哌噻吨美利曲辛 艾司唑仑 功能性消化不良 

分 类 号：R723.11[医药卫生—儿科]